Dr. Chen holds a Ph.D. in Biostatistics from Columbia University.
He previously served as Vice President and Global Head of Biostatistics, Clinical Pharmacology & Pharmacometrics at Bristol-Myers Squibb, where he led the development strategy for multiple oncology and immunotherapy programs and was a member of senior R&D governance committees. He has extensive experience participating in U.S. FDA advisory meetings and has co-chaired multiple cross-industry statistical working groups. He previously held an adjunct faculty appointment in the Department of Biostatistics at Columbia University.
Dr. Chen is currently Vice President and Global Head of Oncology Biostatistics at GlaxoSmithKline (GSK), and concurrently serves as Interim Head of Asia (China/Japan) Development Biostatistics. He leads initiatives in strategic data analysis, drug evaluation, and market access modeling.